Polymeric Drug Delivery of Platinum-Based Anticancer Agents

被引：112

作者：

Haxton, Katherine J. ^{[1
,2
]}

Burt, Helen M. ^{[1
]}

机构：

[1] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada

[2] Keele Univ, Sch Phys & Geog Sci, Keele ST5 5BG, Staffs, England

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 2009年 / 98卷 / 07期

基金：

加拿大健康研究院; 加拿大自然科学与工程研究理事会;

关键词：

polymeric drug delivery systems; polymers; dendrimers; nanoparticles; biodegradable polymers; microparticles; macromolecular drug delivery; macromolecular prodrugs; micelle; PLGA-MPEG NANOPARTICLES; METAL COMPLEX MICELLE; ANTITUMOR-ACTIVITY; CLINICAL PHARMACOKINETICS; CISPLATIN DELIVERY; ESCHERICHIA-COLI; PROSTATE-CANCER; BLOCK-COPOLYMER; CELL-DIVISION; PHASE-I;

D O I：

10.1002/jps.21611

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Platinum-based anticancer agents such as cisplatin and carboplatin are in widespread clinical use but associated with many side effects. Improving the delivery of cytotoxic platinum compounds may lead to reduced side effects and achieve greater efficacy at lower doses. Polymer-based therapeutics have been investigated as potential drug delivery vehicles for platinum-based drugs. Against a background of the chemistry and pharmacology of cytotoxic platinum compounds, this review discusses the formation and properties of platinum-polymer complexes, dendrimers, micelles, and microparticulates. (C) 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:2299-2316, 2009

引用

页码：2299 / 2316

页数：18

共 137 条

[91] Improved understanding in platinum antitumour chemistry [J].

Reedijk, J .

CHEMICAL COMMUNICATIONS, 1996, (07) :801-806

[92] Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system [J].

Rice, JR ;

Gerberich, JL ;

Nowotnik, DP ;

Howell, SB .

CLINICAL CANCER RESEARCH, 2006, 12 (07) :2248-2254

[93] Micellization of block copolymers [J].

Riess, G .

PROGRESS IN POLYMER SCIENCE, 2003, 28 (07) :1107-1170

[94] Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel [J].

Rixe, O ;

Ortuzar, W ;

Alvarez, M ;

Parker, R ;

Reed, E ;

Paull, K ;

Fojo, T .

BIOCHEMICAL PHARMACOLOGY, 1996, 52 (12) :1855-1865

[95] PLATINUM COMPOUNDS - A NEW CLASS OF POTENT ANTITUMOUR AGENTS [J].

ROSENBERG, B ;

VANCAMP, L ;

TROSKO, JE ;

MANSOUR, VH .

NATURE, 1969, 222 (5191) :385-+

[96] INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE [J].

ROSENBERG, B ;

VANCAMP, L ;

KRIGAS, T .

NATURE, 1965, 205 (4972) :698-+

[97]

ROSENBERG B, 1967, J BIOL CHEM, V242, P1347

[98] Ototoxicity: therapeutic opportunities [J].

Rybak, LP ;

Whitworth, CA .

DRUG DISCOVERY TODAY, 2005, 10 (19) :1313-1321

[99] Polymer therapeutics for cancer: Current status and future challenges [J].

Satchi-Fainaro, R ;

Duncan, R ;

Barnes, CM .

POLYMER THERAPEUTICS II: POLYMERS AS DRUGS, CONJUGATES AND GENE DELIVERY SYSTEMS, 2006, 193 (1-65) :1-65

[100]

Schechter B, 2000, APPL ORGANOMET CHEM, V14, P701, DOI 10.1002/1099-0739(200011)14:11<701::AID-AOC26>3.0.CO

← 5 6 7 8 9 10 11 12 13 14 →